Our Relationships

Innovative companies, successful investors

We partner with many of the most innovative, public and private biopharma companies in the industry, at the most formative stages of their life cycles – from discovery, development and into commercialization and throughout all stages of capitalization. 

Our clients are supported by some of the most sophisticated investors the space, who believe in leaders who can advance paradigm-changing science and develop life-saving therapeutics for patients. 

 Biopharma


  • Aerium Therapeutics
  • AvroBio
  • Blueprint Medicines
  • C4 Therapeutics
  • Carisma
  • Chinook
  • CODIAK
  • Crisper
  • dbv Technologies
  • editas Medicine
  • Frequenct Theraputics
  • Hotspot Therapeutics
  • Korro Bio
  • KSQ
  • KYMERA
  • MarcoGenics
  • Merus
  • Mirati
  • Monte Rosa
  • Nuvation Bio
  • Prelude
  • Provention Bio
  • Rectify Pharma
  • Remix
  • ribon
  • Rhythm
  • Sarepta
  • Seagen
  • Second Genome
  • Solid Biosciences
  • Spero
  • Tallac
  • tenaya
  • xilio

 Investors


  • ALEXANDRIA
  • Arch
  • Blackstone
  • Casdin
  • Column Group
  • forbion
  • Foresite Capital
  • F Prime
  • Frazier
  • GV
  • Khosla ventures
  • Lightstone
  • Longitude Capital
  • Lundbeckfond
  • mpm
  • NEA
  • NVF
  • novo holdings
  • omega Funds
  • OrbiMed
  • Perspective Advisors
  • Pfizer
  • Polaris
  • ra capital
  • section 32
  • SOFINNOVA
  • SR ONE
  • SV HEALTH INVESTORS
  • THIRD ROCK
  • TPG
  • VEN BIO
  • VENROCK
  • VERSANT
  • VIDA

Follow us on Twitter and LinkedIn to stay updated on announcements, news, and opportunities.